Analyst Ratings for Travere Therapeutics (TVTX)
TVTX Rating Summary
TVTX Price Target Summary
- Highest: $85.00 (Citi)
- Lowest: $35.00 (Evercore ISI)
- Average: $64.38
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$64.38 (-2%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$64.38 (-2%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/14/2026 | Piper Sandler » Updated 8/17/2026 |
Allison M. Bratzel | Upgrade | Overweight (Neutral) |
68.00 (49.00) |
30.70 (65.71) |
114.04% | Details |
| 8/25/2025 | Evercore ISI » Updated 10/1/2025 |
Gavin Clark-Gartner | New Coverage | Outperform (N/A) |
35.00 (45.00) |
17.92 (65.71) |
266.69% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
